For Immediate Release – December 16, 2021
Contact: Faith Folb, COO, SDC
SDC EXPANDS BIOSTATISTICS TEAM WITH DR HELEN LI
Tempe, AZ, December 16, 2021 — In conjunction with celebrating 16 years as a top-tier provider, SDC is proud to announce the addition of Helen Li, Sc.D. as Vice President, Biostatistics & Consulting – Regulatory & Education. Dr. Li has over 20 years of regulatory and pharmaceutical industry experience, with more than 15 years at the FDA, and most recently in leadership roles at Bristol Myers Squibb and Regeneron Pharmaceuticals. Dr. Li received her Biostatistics training from Harvard School of Public Health. Her focus at SDC will be on strategic and scientific consulting, mentoring, and developing biostatistical knowledge, and providing strong regulatory guidance to our clients.
“SDC is extremely excited to welcome Dr. Li to our already very strong team,” said Richard Abelson, Ph.D., President & CEO at SDC. “Helen’s broad and extensive experience will support our continued growth as the premier provider of biometrics services to our pharma, biologics, and medical device clients.” SDC’s team has a proven track record of guiding our client’s programs from initial designs through regulatory approvals with 20+ product approvals.
In addition to the extensive experience referenced above, Dr. Li has also been very well published over the course of her career with contributions to more than 15 papers in peer-reviewed publications and over 40 key presentations. Her therapeutic area coverage has included oncology, ophthalmology, neurology, cell therapy, hematology, cardiovascular, anti-inflammatory, anti-infective, transplant, pulmonary, diabetic, and allergy.
“Dr. Li’s regulatory expertise and well-established leadership in developing new methodologies that solve problems in clinical trials will add to SDC’s core tenet of operational and customer management excellence in Data Management and Biostatistics.”
“Helen brings extensive skills and leadership in developing innovative study designs, which is a hallmark of SDC. She joins our team of seasoned biostatisticians and strategic consulting experts and will contribute heavily to SDC’s continued success in providing high-quality and trusted statistical and regulatory consultation to clients. In addition, we look forward to Helen developing statisticians who are early in their careers into excellent and productive consultants and study leads,” said Adam Hamm, SVP Biostatistics and Strategic Consulting.
SDC has been delivering top-tier clinical trial services to pharmaceutical, biologic, and medical device/diagnostic companies since 2005. We are committed to providing experienced teams who will take ownership of your needs and remain positively engaged in your projects. With strategic scientific consulting and clinical data services (biostatistics, data management/EDC, and IRT/IWRS) expertise at our core, our services are scalable via our diverse and complementary strategic partnerships to provide full-service clinical trial solutions. Speak with us today to see why SDC is The Right Fit For You. ®
If you would like more information about this topic, please email email@example.com.